1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Overactive Bladder Treatment Market
3.2. Opportunities in the Overactive Bladder Treatment Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Overactive Bladder Treatment Market, by Therapy Type
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Anticholinergic
5.4. BOTO
5.5. Darifenacin
5.6. Fesoterodine
5.7. Mirabegron
5.8. Neurostimulation
5.9. Oxybutynin
5.10. Solifenacin
6. Global Overactive Bladder Treatment Market, by Disease Type
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Idiopathic Bladder Overactivity
6.4. Neurogenic Bladder Overactivity
7. Global Overactive Bladder Treatment Market, by Geography
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Americas
7.3.1. Overview
7.3.2. Market Sizing & Forecasting
7.3.3. Argentina
7.3.4. Brazil
7.3.5. Canada
7.3.6. Mexico
7.3.7. United States
7.4. Asia-Pacific
7.4.1. Overview
7.4.2. Market Sizing & Forecasting
7.4.3. Australia
7.4.4. China
7.4.5. India
7.4.6. Japan
7.5. Europe, Middle East & Africa
7.5.1. Overview
7.5.2. Market Sizing & Forecasting
7.5.3. France
7.5.4. Germany
7.5.5. Italy
7.5.6. Spain
7.5.7. United Kingdom
8. Competitive Landscape
8.1. 360iResearch FPNV Positioning Matrix for Global Overactive Bladder Treatment Market
8.2. Market Vendor Ranking Analysis for Global Overactive Bladder Treatment Market
8.3. Competitive News Feed Analysis for Global Overactive Bladder Treatment Market
9. Company Usability Profiles
9.1. Apotex Inc.
9.1.1. Overview
9.1.2. Strategy
9.1.3. SWOT
9.2. Aurobindo Pharma Limited
9.2.1. Overview
9.2.2. Strategy
9.2.3. SWOT
9.3. Intas Biopharmaceuticals
9.3.1. Overview
9.3.2. Strategy
9.3.3. SWOT
9.4. Johnson & Johnson
9.4.1. Overview
9.4.2. Strategy
9.4.3. SWOT
9.5. Medtronic plc
9.5.1. Overview
9.5.2. Strategy
9.5.3. SWOT
9.6. Allergan plc
9.7. Endo International plc.
9.8. Hisamitsu Pharmaceutical Co., Inc.
9.9. Mylan N.V.
9.10. Sanofi S.A.
10. Appendix
10.1. Discussion Guide
10.2. Top Reports
10.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
10.3. Author Details